美国ＦＤＡ最近批准一种称为ＮｅｏＴｅｃｔ的新药上市,由于它能照亮癌细胞,因此,它为胸部Ｘ光透视发现可疑阴影的患者,提供了新检验方法,帮助医生判定患者是否需做肺癌活体切片检验。该药由美国戴泰德公司制造,它与其他非侵害性癌症检验法的功能不同,它在决定患者是否需要做活 The U.S. FDA recently approved the launch of a new drug called NeoTect that, because of its ability to light cancer cells, provided a new test for patients with suspicious shadows in chest X-rays that help doctors determine if a patient needs to have lung cancer live Slice inspection. The drug, manufactured by Dayton, USA, does not function like any other non-invasive cancer test and is used to determine whether patients need to be alive